Patient Cases in Ovarian Cancer Screening and Management to Improve Survival
Among women in the United States, ovarian cancer is the leading cause of death from gynecologic malignancy and the fifth-leading cause of cancer-related death. The high mortality rate associated with ovarian cancer is due in part to the lack of effective screening strategies to detect the disease in early stages (I or II) when the cancer is confined to the ovary. Since symptoms associated with ovarian cancer are typically nonspecific, it is difficult to make a clinical diagnosis until the disease has advanced.

This activity involves three patient cases that focus on specific topics from an April 2010 webinar that provided details on early detection of ovarian cancer, pelvic mass risk assessment, and management issues of neoadjuvant chemotherapy and recurrent disease.

Upon completion, participants should be able to:
• Evaluate the risks and benefits of ovarian cancer surveillance vs. prophylactic oophorectomy in the presence of BRCA mutation;
• Identify patients who should be referred to a gynecologic oncologist for cytoreductive surgery and surgical staging of ovarian cancer;
• Discuss low-grade ovarian carcinoma.

» Go to this activity

You are subscribed to ModernMedicine.com. To unsubscribe, click here

To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.